ContraVir Pharmaceuticals Inc (OTCBB - OTCQB:CTRV)

2.00
Data as of Apr 17
 +0.02 / +1.01%
Today’s Change
0.01
Today|||52-Week Range
3.10
--
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$37.9M

Company Description

ContraVir Pharmaceuticals, Inc. is a development stage biopharmaceutical company which is focused primarily on the development of drugs to treat herpes zoster, or shingles. The company currently developing a compound called FV-100 for the treatment of shingles. ContraVir Pharmaceuticals was founded on May 15, 2013 and is Headquartered in New York, NY.

Contact Information

ContraVir Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:

Employees

Shareholders

Mutual fund holders3.44%
Other institutional3.09%
Individual stakeholders0.22%

Top Executives

James SapirsteinChief Executive Officer & Director
Bernard F. DenoyerChief Financial Officer, Secretary & Senior VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.